ENGN
enGene Therapeutics Inc. Common Stock
stockNASDAQ
At CloseNov 13, 2026 3:59:55 PM EST
2.42USD+6.140%(+0.14)3,700,940
Pre-marketNov 13, 2026 9:29:30 AM EST
2.44USD+7.018%(+0.16)
After-hoursNov 13, 2026 4:55:30 PM EST
2.3707USD-2.037%(-0.0493)
ENGN Financials
In Q3 FY 2026 (ended ), enGene Therapeutics Inc. Common Stock (ENGN) reported net income of −$32.5M, operating cash flow of −$18.95M, and assets of $288.32M (filed ).
Loading financial statements…